Related Experiment Video
Updated: Jun 13, 2026

07:46
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
[Obesity and atherosclerosis--what's the link?]
13. interní klinika 1, lékarské fakulty UK a VFN Praha. petr.sucharda@lf1.cuni.cz
Vnitrni Lekarstvi
|May 15, 2010
Summary
Abdominal obesity is a major risk factor for atherosclerosis, linked to lifestyle changes. Metabolic syndrome, driven by adipose tissue dysfunction, significantly elevates this risk.
Area of Science:
- Cardiovascular Medicine
- Metabolic Health
- Public Health
Background:
- Obesity, particularly abdominal obesity, is a significant risk factor for symptomatic atherosclerosis.
- Modern lifestyle factors, including dietary changes and reduced physical activity, contribute to the obesity pandemic and associated vascular issues.
- The civilization process has led to increased prevalence of obesity and atherosclerosis.
Purpose of the Study:
- To highlight the link between obesity, metabolic syndrome, and atherosclerosis.
- To emphasize the role of adipose tissue dysfunction in driving atherosclerotic risk.
Main Methods:
- Review of epidemiological data on obesity and atherosclerosis.
- Analysis of the pathophysiological mechanisms connecting obesity, inflammation, and endothelial dysfunction.
- Clinical definition and risk assessment of metabolic syndrome.
Main Results:
- Abdominal obesity is a primary driver of symptomatic atherosclerosis.
- Adipose tissue dysfunction leads to low-grade inflammation and endothelial dysfunction.
- Metabolic syndrome is a prominent atherosclerotic risk factor.
Conclusions:
- Obesity, especially abdominal obesity, poses a substantial risk for atherosclerosis.
- Metabolic syndrome, characterized by adipose tissue dysfunction, is a key factor in atherosclerotic vascular disease development.
- Lifestyle interventions targeting obesity and metabolic syndrome are crucial for cardiovascular health.
More Related Videos
Related Concept Videos
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
